医学部

松本 省二

マツモト ショウジ  (Shoji Matsumoto)

基本情報

所属
藤田医科大学 医学部 脳卒中科 教授
学位
博士 (医学)(九州大学)

J-GLOBAL ID
201801011682533471
researchmap会員ID
B000307191

香川県高松市生まれ。1996年に富山医科薬科大学医学部を卒業後九州大学神経内科に入局、佐賀医科大学病院、九州大学病院、麻生飯塚病院で臨床神経内科学の臨床研究を行った。その後、国立循環器病研究センター、福岡市民病院、小倉記念病院、九州大学病院、済生会福岡病院、藤田医科大学で主に脳梗塞診療プロセスの改善と教育、そのICT支援に関する研究を中心に行っている。ICTを活用することで、脳卒中診療に関わるスタッフの想いや技術を全国の脳卒中患者さんに効果的に届けることで、脳卒中のダメージを最小限にすることがメインテーマである。


学歴

 1

論文

 90
  • Hirano G., Teramoto A., Takai H., Sasaki Y., Sugimoto K., Matsumoto S., Saito K., Fujita H.
    J Med Ultrason (2001). 2025 Apr 17. doi: 10.1007/s10396-025-01522-7. Epub ahead of print. PMID: 40244313. 2025年4月  査読有り
  • 桑原 聖典, 中原 一郎, 松本 省二, 須山 嘉雄, 盛岡 潤, 長谷部 朗子, 田邉 淳, 渡邉 定克, 陶山 謙一郎, 廣瀬 雄一
    脳卒中の外科 52(3) 210-217 2024年5月  
  • Kiyonori Kuwahara, Ichiro Nakahara, Shoji Matsumoto, Yoshio Suyama, Jun Morioka, Akiko Hasebe, Jun Tanabe, Sadayoshi Watanabe, Kenichiro Suyama, Yuichi Hirose
    Radiology case reports 19(5) 1692-1696 2024年5月  
    It is impossible to predict underlying anomalies in acute large vessel occlusion and it could be a problem when performing mechanical thrombectomy (MT). We report a case of MT for occlusion of the fenestrated middle cerebral artery (MCA) M1 segment. A 49-year-old woman presented to our hospital with dysarthria and left hemiparesis. Acute ischemic stroke due to right occluded MCA was diagnosed. During performing emergent MT, a part of the M1 segment was revealed to be slit-shaped by digital subtraction angiography, suggesting a fenestrated MCA. The aspiration catheter could not be advanced through the narrow limb of the fenestration, and the distal thrombus was retrieved using a stent retriever, additionally. Postoperatively, the patient's symptoms improved without complications. When occlusion of the fenestrated MCA is suspected, it is necessary to consider converting the strategy from an aspiration catheter alone to the combined use of a stent retriever.
  • Kenichiro Suyama, Ichiro Nakahara, Shoji Matsumoto, Jun Morioka, Jun Tanabe, Akiko Hasebe, Sadayoshi Watanabe
    Clinical neuroradiology 34(1) 201-208 2024年3月  
    PURPOSE: Prasugrel is not approved for patients treated with flow diverters, which have a high metal coverage ratio. However, robust antiplatelet therapy with prasugrel may prevent thromboembolic complications. We administered prasugrel and aspirin to all patients treated with flow diverters and reported the safety of the antiplatelet therapy regimen. METHODS: This retrospective, single-center study evaluated the angiographic and clinical data of consecutive patients treated with flow diverters for cerebral unruptured aneurysms between June 2020 and May 2022. All patients received dual antiplatelet therapy, including prasugrel and aspirin. The administration of prasugrel ended 3 or 6 months after the procedure, whereas aspirin use continued for at least 12 months. Periprocedural complications (< 30 days post-procedure) and delayed complications (> 30 days post-procedure) were recorded. RESULTS: During the study period, 120 unruptured aneurysms were treated with flow diverters in 110 patients. All patients, except one, survived longer than 12 months after the procedure. The rate of thromboembolic complications was 6.4%, and more than half of the patients had transient symptoms; one (0.9%) had a major ischemic stroke. One patient (0.9%) each had an asymptomatic, small subarachnoid hemorrhage and significant hemorrhagic complications with melena. The rate of permanent neurological deficits was 1.8%, and the mortality rate was 0.9%. CONCLUSIONS: Dual antiplatelet therapy comprising routine use of prasugrel and aspirin for flow diverter-implanted patients possibly contributed to a low rate of thromboembolic complications and low risk of hemorrhagic complications.
  • Takeya Suzuki, Ichiro Nakahara, Sadayoshi Watanabe, Shoji Matsumoto, Jun Morioka, Tetsuya Hashimoto, Akiko Hasebe, Jun Tanabe, Kenichiro Suyama, Junpei Koge
    Journal of neuroendovascular therapy 18(9) 250-255 2024年  
    OBJECTIVE: LEONIS Mova (SB-KAWASUMI LABORATORIES, Kanagawa, Japan, hereinafter called LEONIS Mova) is a steerable microcatheter (MC) that enables angle adjustment of the catheter tip using a hand-operated dial. LEONIS Mova may be useful for flow diverter placement when access to the distal parent artery with a conventional MC and microguidewire (MGW) is considered difficult or impossible. Here, we report three such cases encountered during flow diverter placement in large and giant internal carotid artery aneurysms. CASE PRESENTATION: In Case 1, a strong S-shaped curve was observed in the proximal parent artery of a giant cerebral aneurysm, and the luminal structure of the parent artery was lost within the aneurysm. It was anticipated that the distal side of the parent artery would be difficult to access with conventional MC and MGW. By adjusting the tip of the LEONIS Mova toward the aneurysm outlet beyond the S-shaped curve, it was possible to induce the MGW to secure the distal parent artery easily. In Case 2, the inflow and outflow axes of the parent artery were completely misaligned at the site of the aneurysm, and stenosis was present in the distal parent artery. Firmly bending the catheter tip increased accommodation for the catheter, enabling the induction of an MGW to access the distal parent artery without kicking back. In Case 3, the lesion extended from the cavernous portion to the petrosal portion; however, by adjusting the tip of the LEONIS Mova toward the aneurysm outlet, it was possible to induce the MGW to secure the distal parent artery easily. In each case, the LEONIS Mova enabled more secure and prompt access to the parent artery than anticipated and facilitated flow diverter placement. CONCLUSION: Encountering difficult-to-access lesions is one reason endovascular treatment may be unsuccessful. The LEONIS Mova is an excellent device that can overcome this obstacle, and its utility in certain applications should be recognized.

MISC

 278

講演・口頭発表等

 77

共同研究・競争的資金等の研究課題

 8